Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
ASOs, CBOs and Pharmacists: Untapped Partnerships for Success
Review of how HIV care can be enhanced when agencies establish partnerships with pharmacists.Resource updated 08/28/2023
-
CAREWare Data Sharing Consent
Consent form for clients to authorize the sharing of their patient information among HIV care providers in the CAREWare system.
Resource updated 09/19/2023
-
Rapid ART: An Essential Strategy to End the HIV Epidemic
Insights for entities seeking to create or strengthen rapid ART.Resource updated 03/15/2023
-
CAREWare Confidentiality and Nondisclosure Statement
Sample agreement submitted via the CAREWare listserv.
Resource updated 09/19/2023
-
CAREWare 6 Miscellaneous Features Guide
Instructions on application of the following features in CAREWare 6: Cap on Charges, Required Data Elements, Provider Summary, and HIVQM File Export.Resource updated 09/19/2023
-
CAREWare User Agreement
Sample user agreement submitted via the CAREWare listserv.
Resource updated 09/19/2023
-
HIVQM File Export: An excerpt from Miscellaneous Features Guide
Step-by-step instructions on how to create a .CSV file in CAREWare to upload to the HIVQM Module.Resource updated 09/19/2023
-
Tips and Tricks to Managing Stressful Practice Transitions
This discussion will give an overview of the methods and techniques used to handle a workforce that was comfortable with the status quo after 20 years of using CAREWare versions 1 through 5 and not ready to give in to change very quickly.
Learning Objectives
- Understand underlying causes of resistance to change.
- Describe methods of handling anxiety over change.
- Discuss ways to address self-care in times of managing the workforce stress over inevitable change.
Resource (Conference Presentation) updated 09/14/2023
-
Adolescent Viral Load Suppression: Challenges and Success Stories
Resource (Conference Presentation) updated 09/14/2023
-
Average Time to Initiation of Antiretroviral Therapy - Newly Diagnosed HIV Patients - University of Utah
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
-
HCV Linkage, Screening, and Treatment among Co-infected Clients: Enhancing CAREWare and Electronic Health Records
As HIV elimination activities increase, jurisdictions can address HIV/Hepatitis C (HCV) co-infection by enhancing HCV screening and treatment data collection. This session will discuss NASTAD's work with North Carolina to incorporate HCV data in CAREWare and electronic health records (EHRs), as well as recommendations for integrating HCV services into the HIV care infrastructure.
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access for HIV Care and Prevention in a Center for Youth
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
-
Proactive Clinic-Based Substance Abuse Screening and Treatment: Helping to Advance in New Directions (Helping HAND)
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
-
Test-and-Treat Protocol in a Rural State To Decrease Time to Undetectable Viral Load
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
-
Managing Multiple Data Sources and Overcoming Interoperability Barriers for HIV Care
This session will help recipient and subrecipient sites to successfully connect their CAREWare and other electronic health information systems with external sources of data to report and monitor HIV care and treatment outcomes. This session will provide practical examples of successful data integration and highlight ongoing issues and costs in long-term management and maintenance.
Resource (Conference Presentation) updated 09/14/2023
-
Centralized Eligibility and Unified CAREWare
The presentation will describe how CAREWare and eligibility integration eased access to services by clients in our jurisdictions. Presenters will be to provide Ryan White jurisdictions with actionable ideas and processes to integrate their CAREWare and eligibility processes to improve access to services, reporting, monitoring, and quality management.
Learning Objectives
- Understand data sharing agreements and policy.
- Understand benefits of joint eligibility.
- Understand benefits of a unified and integrated CAREWare data system.
Resource (Conference Presentation) updated 09/14/2023
-
CAREWare 6 User Input and Future Directions
CAREWare users can provide input on all CAREWare 6 software components, including ease of use, design, reports, and other features. This session will address challenges with specific features like setup, administration, generating reports, and basic data entry.
Resource (Conference Presentation) updated 09/14/2023
-
Long-Acting ART HIV Treatment Regimens: Key Behavioral Considerations for Stakeholders
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023